A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer

Clinical trial NCT07623356 · RECRUITING

Trial details

NCT number: NCT07623356
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2026-07-07
Primary completion: 2028-06-18
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.